6.
Juskevicius D, Dirnhofer S, Tzankov A
. Genetic background and evolution of relapses in aggressive B-cell lymphomas. Haematologica. 2017; 102(7):1139-1149.
PMC: 5566014.
DOI: 10.3324/haematol.2016.151647.
View
7.
Benjamens S, Dhunnoo P, Mesko B
. The state of artificial intelligence-based FDA-approved medical devices and algorithms: an online database. NPJ Digit Med. 2020; 3:118.
PMC: 7486909.
DOI: 10.1038/s41746-020-00324-0.
View
8.
Akthar A, Ferguson M, Koshy M, Vigneswaran W, Malik R
. Limitations of PET/CT in the Detection of Occult N1 Metastasis in Clinical Stage I(T1-2aN0) Non-Small Cell Lung Cancer for Staging Prior to Stereotactic Body Radiotherapy. Technol Cancer Res Treat. 2016; 16(1):15-21.
PMC: 5616110.
DOI: 10.1177/1533034615624045.
View
9.
Khanna N, Maindarkar M, Viswanathan V, Fernandes J, Paul S, Bhagawati M
. Economics of Artificial Intelligence in Healthcare: Diagnosis vs. Treatment. Healthcare (Basel). 2022; 10(12).
PMC: 9777836.
DOI: 10.3390/healthcare10122493.
View
10.
Steyaert S, Pizurica M, Nagaraj D, Khandelwal P, Hernandez-Boussard T, Gentles A
. Multimodal data fusion for cancer biomarker discovery with deep learning. Nat Mach Intell. 2023; 5(4):351-362.
PMC: 10484010.
DOI: 10.1038/s42256-023-00633-5.
View
11.
Chang Q, Yan Z, Zhou M, Qu H, He X, Zhang H
. Mining multi-center heterogeneous medical data with distributed synthetic learning. Nat Commun. 2023; 14(1):5510.
PMC: 10484909.
DOI: 10.1038/s41467-023-40687-y.
View
12.
Menyhart O, Gyorffy B
. Multi-omics approaches in cancer research with applications in tumor subtyping, prognosis, and diagnosis. Comput Struct Biotechnol J. 2021; 19:949-960.
PMC: 7868685.
DOI: 10.1016/j.csbj.2021.01.009.
View
13.
Vokinger K, Hwang T, Daniore P, Lee C, Tibau A, Grischott T
. Analysis of Launch and Postapproval Cancer Drug Pricing, Clinical Benefit, and Policy Implications in the US and Europe. JAMA Oncol. 2021; 7(9):e212026.
PMC: 8251654.
DOI: 10.1001/jamaoncol.2021.2026.
View
14.
Spin-Neto R, Costa C, Salgado D, Zambrana N, Gotfredsen E, Wenzel A
. Patient movement characteristics and the impact on CBCT image quality and interpretability. Dentomaxillofac Radiol. 2017; 47(1):20170216.
PMC: 5965740.
DOI: 10.1259/dmfr.20170216.
View
15.
Zhang Y, Sun B, Yu Y, Lu J, Lou Y, Qian F
. Multimodal fusion of liquid biopsy and CT enhances differential diagnosis of early-stage lung adenocarcinoma. NPJ Precis Oncol. 2024; 8(1):50.
PMC: 10897137.
DOI: 10.1038/s41698-024-00551-8.
View
16.
Tong Y, Udupa J, Chong E, Winchell N, Sun C, Zou Y
. Prediction of lymphoma response to CAR T cells by deep learning-based image analysis. PLoS One. 2023; 18(7):e0282573.
PMC: 10361488.
DOI: 10.1371/journal.pone.0282573.
View
17.
Loeffler-Wirth H, Kreuz M, Hopp L, Arakelyan A, Haake A, Cogliatti S
. A modular transcriptome map of mature B cell lymphomas. Genome Med. 2019; 11(1):27.
PMC: 6492344.
DOI: 10.1186/s13073-019-0637-7.
View
18.
Singh S, Kumar R, Payra S, Singh S
. Artificial Intelligence and Machine Learning in Pharmacological Research: Bridging the Gap Between Data and Drug Discovery. Cureus. 2023; 15(8):e44359.
PMC: 10539991.
DOI: 10.7759/cureus.44359.
View
19.
Appelbaum J, Milano F
. Hematopoietic Stem Cell Transplantation in the Era of Engineered Cell Therapy. Curr Hematol Malig Rep. 2018; 13(6):484-493.
PMC: 6333424.
DOI: 10.1007/s11899-018-0476-4.
View
20.
Koh D, Papanikolaou N, Bick U, Illing R, Kahn Jr C, Kalpathi-Cramer J
. Artificial intelligence and machine learning in cancer imaging. Commun Med (Lond). 2022; 2:133.
PMC: 9613681.
DOI: 10.1038/s43856-022-00199-0.
View